Loading

RLT-PSMA

18F-PSMA-1007 PET/CT Detects Isolated Rectal Metastases

Researchers analyzed a case of a 66-year-old patient who was diagnosed with prostate cancer infiltrating the rectum along with solitary rectal metastases that were staged using 18F-PSMA-1007 PET/CT. The whole-body scan was able to detect multiple foci of abnormal tracer uptake in the pelvis and abdomen. The PET/CT and contrast-enhanced computed tomography images showed an increased uptake of radiotracer in primary tumor in residual prostate gland infiltrating the neck of urinary bladder, rectum, levator ani, and obturator muscles with pelvic ...

Advertisement

Latest News

Advertisement

Videos

Prostate Cancer Knowledge Hubs

Curated clinical content on prostate cancer types, therapies, and technologies

Prostate Cancer
Prostate Cancer

Conference Coverage

Advertisement
Advertisement
Expert Discussions

Akhil Abraham Saji, MD

RLT-PSMA | August 9, 2022

Akhil Saji, MD, interviews Ida Sonni, MD, about using PSMA-PET to better understand recurrence risk and inform therapy plans.

Akhil Abraham Saji, MD

RLT-PSMA | August 15, 2022

Dr. Saji continues his interview with Dr. Sonni about using PSMA-PET to understand recurrence risk and inform therapy plans.

GU Oncology Now Editors

Roundtable | April 6, 2022

Panel experts discuss PSMA-targeting agents currently being assessed, including PSMA-I&T-Lutetium-177.